148 related articles for article (PubMed ID: 23528797)
1. Towards the bioequivalence of pressurised metered dose inhalers 2. Aerodynamically equivalent particles (with and without glycerol) exhibit different biopharmaceutical profiles in vitro.
Haghi M; Bebawy M; Colombo P; Forbes B; Lewis DA; Salama R; Traini D; Young PM
Eur J Pharm Biopharm; 2014 Jan; 86(1):38-45. PubMed ID: 23528797
[TBL] [Abstract][Full Text] [Related]
2. Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.
Lewis DA; Young PM; Buttini F; Church T; Colombo P; Forbes B; Haghi M; Johnson R; O'Shea H; Salama R; Traini D
Eur J Pharm Biopharm; 2014 Jan; 86(1):31-7. PubMed ID: 23523547
[TBL] [Abstract][Full Text] [Related]
3. Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers.
Buttini F; Miozzi M; Balducci AG; Royall PG; Brambilla G; Colombo P; Bettini R; Forbes B
Int J Pharm; 2014 Apr; 465(1-2):42-51. PubMed ID: 24491530
[TBL] [Abstract][Full Text] [Related]
4. Critical characteristics for corticosteroid solution metered dose inhaler bioequivalence.
Grainger CI; Saunders M; Buttini F; Telford R; Merolla LL; Martin GP; Jones SA; Forbes B
Mol Pharm; 2012 Mar; 9(3):563-9. PubMed ID: 22229274
[TBL] [Abstract][Full Text] [Related]
5. How to engineer aerosol particle properties and biopharmaceutical performance of propellant inhalers.
Akhuemokhan P; Green NA; Haddrell A; Lewis D; Reid JP; Forbes B
Int J Pharm; 2023 Mar; 634():122676. PubMed ID: 36738807
[TBL] [Abstract][Full Text] [Related]
6. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
[TBL] [Abstract][Full Text] [Related]
7. In vitro investigation of the effect of ambient humidity on regional delivered dose with solution and suspension MDIs.
Shemirani FM; Hoe S; Lewis D; Church T; Vehring R; Finlay WH
J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):215-22. PubMed ID: 23094687
[TBL] [Abstract][Full Text] [Related]
8. Influence of particle size and patient dosing technique on lung deposition of HFA-beclomethasone from a metered dose inhaler.
Leach CL; Davidson PJ; Hasselquist BE; Boudreau RJ
J Aerosol Med; 2005; 18(4):379-85. PubMed ID: 16379614
[TBL] [Abstract][Full Text] [Related]
9. Is the cellular uptake of respiratory aerosols delivered from different devices equivalent?
Ong HX; Traini D; Loo CY; Sarkissian L; Lauretani G; Scalia S; Young PM
Eur J Pharm Biopharm; 2015 Jun; 93():320-7. PubMed ID: 25930239
[TBL] [Abstract][Full Text] [Related]
10. In vitro cell integrated impactor deposition methodology for the study of aerodynamically relevant size fractions from commercial pressurised metered dose inhalers.
Haghi M; Traini D; Young P
Pharm Res; 2014 Jul; 31(7):1779-87. PubMed ID: 24549816
[TBL] [Abstract][Full Text] [Related]
11. An assessment of beclomethasone dipropionate clathrate formation in a model suspension metered dose inhaler.
Bouhroum A; Burley JC; Champness NR; Toon RC; Jinks PA; Williams PM; Roberts CJ
Int J Pharm; 2010 May; 391(1-2):98-106. PubMed ID: 20184946
[TBL] [Abstract][Full Text] [Related]
12. Co-deposition of a triple therapy drug formulation for the treatment of chronic obstructive pulmonary disease using solution-based pressurised metered dose inhalers.
Adi H; Young PM; Traini D
J Pharm Pharmacol; 2012 Sep; 64(9):1245-53. PubMed ID: 22881437
[TBL] [Abstract][Full Text] [Related]
13. In vitro characterization of the OptiChamber Diamond valved holding chamber.
Hatley RH; von Hollen D; Sandell D; Slator L
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S24-36. PubMed ID: 25054480
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, pharmacodynamics and safety of a novel extrafine BDP/FF/GB combination delivered via metered-dose inhaler in healthy Chinese subjects.
Hu C; Miao J; Shu S; Wang Y; Zhu X; Luo Z
Eur J Pharm Sci; 2020 Mar; 144():105198. PubMed ID: 31862312
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of Beclometasone From Two HFA-BDP Formulations With a Spacer.
Said AS; AbuRuz S; Chrystyn H
Respir Care; 2019 Oct; 64(10):1222-1230. PubMed ID: 31138731
[TBL] [Abstract][Full Text] [Related]
16. Monitoring the initial pulmonary absorption of two different beclomethasone dipropionate aerosols employing a human lung reperfusion model.
Freiwald M; Valotis A; Kirschbaum A; McClellan M; Mürdter T; Fritz P; Friedel G; Thomas M; Högger P
Respir Res; 2005 Feb; 6(1):21. PubMed ID: 15727687
[TBL] [Abstract][Full Text] [Related]
17. Influence of respiratory spacer devices on aerodynamic particle size distribution and fine particle mass of beclomethasone from metered-dose inhalers.
Feddah MR; Davies NM; Gipps EM; Brown KF
J Aerosol Med; 2001; 14(4):477-85. PubMed ID: 11791688
[TBL] [Abstract][Full Text] [Related]
18. The formulation of a pressurized metered dose inhaler containing theophylline for inhalation.
Zhu B; Haghi M; Goud M; Young PM; Traini D
Eur J Pharm Sci; 2015 Aug; 76():68-72. PubMed ID: 25956075
[TBL] [Abstract][Full Text] [Related]
19. The effect of actuator nozzle designs on the electrostatic charge generated in pressurised metered dose inhaler aerosols.
Chen Y; Young PM; Fletcher DF; Chan HK; Long E; Lewis D; Church T; Traini D
Pharm Res; 2015 Apr; 32(4):1237-48. PubMed ID: 25270573
[TBL] [Abstract][Full Text] [Related]
20. A new Pharmaceutical Aerosol Deposition Device on Cell Cultures (PADDOCC) to evaluate pulmonary drug absorption for metered dose dry powder formulations.
Hein S; Bur M; Schaefer UF; Lehr CM
Eur J Pharm Biopharm; 2011 Jan; 77(1):132-8. PubMed ID: 20951200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
